Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →
BBPvsGNOMETF Comparison
Virtus LifeSci Biotech Products ETF (BBP) belongs to the Tomorrow's Treatments segment. Global X Genomics & Biotechnology ETF - USD (GNOM) is part of the BioTech & Genomics segment. Both ETFs have the same top 3 sector exposures: and Health Care. BBP is more expensive with a Total Expense Ratio (TER) of 0.79%, versus 0.5% for GNOM. BBP is up 6.54% year-to-date (YTD) with +$4M in YTD flows. GNOM performs worse with -0.99% YTD performance, and -$2M in YTD flows. Run a side-by-side ETF comparison of BBP and GNOM below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
BBP vs GNOM performance and flow charts
Performance
Cumulative Flows
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | BBP GNOM | +3.49%-2.35% | +9.58%-3.29% | +6.54%-0.99% | +42.80%+29.80% | +83.49%-6.02% | +60.18%-51.80% |
| Flows | BBP GNOM | +$4M- | +$16M-$4M | +$4M-$2M | +$19M-$19M | +$19M-$115M | +$9M+$11M |
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | BBP GNOM | +24.65%+23.45% | +25.47%+30.08% | +23.56%+28.53% | +26.14%+33.47% |
| Max drawdown | BBP GNOM | -7.42%-10.89% | -17.97%-22.14% | -25.54%-46.50% | -38.24%-72.17% |
| Max drawdown duration | BBP GNOM | 32d48d | 106d113d | 292d1031d | 915d1714d |
BBP | GNOM | |
Last sale 3/12/2026 at 1:30 PM | $81.68 | $43.61 |
| Previous close 03/11/2026 | $84.32 | $45.00 |
| Consolidated volume 03/11/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Create an account to view replication metrics
BBP | GNOM | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
BBP | GNOM | |
|---|---|---|
| Last price | $81.68 | $43.61 |
| 1D performance | -3.13% | -3.09% |
| AuM | $50.98 M | $49.36 M |
| E/R | 0.79% | 0.5% |
BBP | GNOM | |
|---|---|---|
| Management strategy | Passive | Passive |
| Provider | VIRTUS Investment Partners | Global X |
| Benchmark | LifeSci Biotechnology Products Index | Solactive Genomics Index |
| N° of holdings | 58 | 46 |
| Asset class | Equities | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | December 16, 2014 | April 5, 2019 |
| ESG | No | No |
Countries
Sectors
Diversification
Total weight of top 15 holdings out of 15
Total weight of top 15 holdings out of 15
Top 15 holdings
How have the BBP and GNOM ETFs performed in 2026?
As of March 10, 2026, BBP is up 6.54% year-to-date (YTD), while GNOM has lost -0.99%. That puts BBP better performer ahead so far this year.
Which ETF is attracting more investor money: BBP or GNOM?
Year-to-date, the BBP ETF saw +$4M in flows, compared to -$2M for GNOM.
Which ETF is more volatile: BBP or GNOM?
Over the past year, BBP had a volatility of 25.47%, while GNOM experienced 30.08%.
Which ETF is bigger: BBP or GNOM?
As of March 10, 2026, BBP holds $50.98 M in assets under management (AUM), while GNOM manages $49.36 M.
What sectors do the BBP and GNOM ETFs invest in?
BBP leans toward sectors like Health Care. Meanwhile, GNOM focuses on Health Care.
What are the top holdings of the BBP ETF and GNOM ETF?
BBP top holdings include DAY ONE BIOPHARMACEUTICALS, DYNAVAX TECHNOLOGIES and AMICUS THERAPEUTICS. GNOM holds in its top three: MODERNA INC, ARROWHEAD PHARMACEUTICALS INC and US74006W2070.
Which ETF is more diversified: BBP or GNOM?
BBP holds 63 securities with 30.11% of its assets in the top 15. GNOM has 48 securities and a top 15 weight of 63.95%.
Active Trader Report: Use of Leveraged & Inverse ETFs Way Up
Direxion partnered with Compound Insights and Vanda to explore what’s driving the evolution of active trading — and how active traders are using leveraged and inverse funds across equities, single stocks, commodities, and volatility.
